Diapin Therapeutics

Diapin Therapeutics is a biotech company focused on the treatment of Type 2 diabetes. It provides a 3 amino acid peptide (DT-109) that, when administered in combination with a glucose challenge, results in increased plasma insulin and glucagon-like 1 (GLP-1) levels and decreased blood glucose levels.